Chronic sucrose intake reduces the antagonist effect of β-funaltrexamine on morphine-induced antinociception in female but not in male rats

References

• Abdollahi M, Nikfar S, Habibi L. 2000. Saccharin effects on morphine-induced antinociception in the mouse formalin test. Pharmacol Res 42:255–259.
   PubMed Web of Science ®Google Scholar
• Adams JU, Andrews JS, Hiller JM, Simon EJ, Holtzman SG. 1987. Effects of stress and ß-funaltrexamine pretreatment on morphine analgesia and opioid binding in rats. Life Sci 41: 2835–2844.
   PubMed Web of Science ®Google Scholar
• Adams JU, Paronis CA, Holtzman SG. 1990. Assessment of relative intrinsic activity of |x-opioid analgesics in vivo using ß- funaltrexamine. J Pharmacol Exp Ther 255:1027–1032.
   PubMed Web of Science ®Google Scholar
• Bartok RE, Craft RM. 1997. Sex differences in opioid antinociception. J Pharmacol Exp Ther 282:769–778.
   PubMed Web of Science ®Google Scholar
• Boyer JS, Morgan RM, Craft RM. 1998. Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res 796:315–318.
   PubMed Web of Science ®Google Scholar
• Carroll ME 1999. Interactions between food and addiction. In: Neisink RJM, et al. editor. Drugs of abuse and addiction: Neurobehavioral toxicology. Boca Raton: CRC Press, p 287–311.
   Google Scholar
• Cicero TJ, Nock B, Meyer ER. 1996. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279:767–773.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Nock B, Meyer ER. 1997. Sex-related differences in morphine’s antinociceptive activity: Relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther 282: 939–944.
   PubMed Web of Science ®Google Scholar
• Craft RM. 2003. Sex differences in drug- and non-drug-induced analgesia. Life Sci 72:2675–2688.
   PubMed Web of Science ®Google Scholar
• Craft RM, Tseng AH, McNiel DM, Furness MS, Rice KC. 2001. Receptor-selective antagonism of opioids antinociception in female versus male rats. Behav Pharmacol 12:591–602.
   PubMed Web of Science ®Google Scholar
• D’Amour FE, Smith DL. 1941. A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79.
   Google Scholar
• D’Anci KE, Kanarek RB, Marks-Kaufman R. 1996. Duration of sucrose availability differentially alters morphine-induced analgesia in rats. Pharmacol Biochem Behav 54:693–697.
   PubMed Web of Science ®Google Scholar
• D’Anci KE, Kanarek RB, Marks-Kaufman R. 1997. Beyond sweet taste: Saccharin, sucrose and polycose differ in their effects upon morphine-induced analgesia. Pharmacol Biochem Behav 56: 341–345.
   PubMed Web of Science ®Google Scholar
• Dum J, Gramsch CH, Herz A. 1983. Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable foods. Pharmacol Biochem Behav 18:443–448.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, D’Anci KE. 2000. Diet and lighting conditions modify the effects of the kappa opioid agonist U50,488H on feeding behavior in rats. Nutr Neurosci 3:231–243.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Homoleski B. 2000. Modulation of morphine-induced antinociception by palatable solutions in male and female rats. Pharmacol Biochem Behav 66:653–659.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Marks-Kaufman R. 1988. Animal models of appetitive behavior: Interaction of nutritional factors and drug seeking behavior. In: Winick M, editor. Control of appetite. New York: Alan R. Liss. p 1–25.
   Google Scholar
• Kanarek RB, White ES, Biegan MT, Marks-Kaufman R. 1991. Dietary influences on morphine-induced analgesia in rats. Pharmacol Biochem Behav 38:681–684.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Przypek J, D’Anci KE, Marks-Kaufman R. 1997a. Dietary modulation of mu- and kappa-opioid receptor mediated analgesia. Pharmacol Biochem Behav 58:43–49.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Mathes WF, Heisler LK, Lima RP, Monfared LS. 1997b. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats. Pharmacol Biochem Behav 57:377–381.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, D’Anci KE, Prypek JM, Mathes WF. 1999. Altering dietary levels of protein or vitamin and minerals does not modify morphine-induced analgesia in male rats. Pharmacol Biochem Behav 62:203–208.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Homoleski B, Wiatr C. 2000. Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats. Pharmacol Biochem Behav 65:97–104.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Mandillo S, Wiatr C. 2001. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats. Brain Res 920:97–105.
   PubMed Web of Science ®Google Scholar
• Kest B, Wilson SG, Mogil JS. 1999. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289:1370–1375.
   PubMed Web of Science ®Google Scholar
• Lett BT. 1989. Ingestion of sweet water enhances the rewarding effect of morphine in rats. Psychobiology 17:191–194.
   Google Scholar
• Liu-Chen L-Y, Yang HH, Li S, Adams JU. 1995. Effect of intracerebroventricular beta-funaltrexamine on fx-opioid receptors in the rat brain: Consideration of binding condition. J Pharmacol Exp Ther 273:1047–1056.
   PubMed Web of Science ®Google Scholar
• Marks-Kaufman R, Hamm MW, Barbato GF. 1989. The effects of dietary sucrose on opiate receptor binding in genetically obese (ob/ob) and lean mice. J Am Coll Nutr 8:9–14.
   PubMed Web of Science ®Google Scholar
• Mjanger E, Yaksh TL. 1991. Characteristics of dose-dependent antagonism by ß-funaltrexamine of the antinociceptive effects of intrathecal mu agonists. J Pharmacol Exp Ther 258:544–550.
   PubMed Web of Science ®Google Scholar
• Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF. 2000. Sex differences in thermal nociception and morphine antinociception in rodents depends on genotype. Neurosci Biobehav Rev 24:375–389.
   PubMed Web of Science ®Google Scholar
• Morgan D, Picker MJ. 1996. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: Importance of the drug’s intrinsic efficacy at the mu receptor. Behav Pharmacol 7:261–284.
   PubMed Web of Science ®Google Scholar
• Negus SS, Pasternak GV, Koob GF, Weinger MB. 1993. Antagonist effects of beta-funaltrexamine and naloxonazine on affentanil- induced antinociception and muscle rigidity in the rat. J Pharmacol Exp Ther 264:739–745.
   PubMed Web of Science ®Google Scholar
• Nikfar S, Abdollahi M, Etemad F, Sarkarati F. 1997. Effect of sweetening agents on morphine-induced analgesia in mice by formalin test. Gen Pharmacol 29:583–586.
   PubMedGoogle Scholar
• Nikfar S, Abdollahi M, Sarkarati F, Etemad F. 1998. Interaction between calcium channel blockers and sweetening agents on morphine-induced analgesia in mice by formalin test. Gen Pharmacol 31:431–435.
   PubMedGoogle Scholar
• Nozaki C, Saitoh A, Kamei J. 2006. Characterization of the antinociceptive effects of oxycodone in diabetic mice. Eur J Pharmacol 535:145–151.
   PubMed Web of Science ®Google Scholar
• Rauhut AS, Gehrke BJ, Phillips SB, Bardo MT. 2002. Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine. Pharmacol Biochem Behav 73:611–622.
   PubMed Web of Science ®Google Scholar
• Roane DS, Martin RJ. 1990. Continuous sucrose feeding decreases pain threshold and increases morphine potency. Pharmacol Biochem Behav 35:225–229.
   PubMed Web of Science ®Google Scholar
• Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW. 1988. ß-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence. J Pharmacol Exp Ther 247:405–416.
   PubMed Web of Science ®Google Scholar
• Stoffel EC, Ulibarri CM, Craft RM. 2003. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103:285–302.
   PubMed Web of Science ®Google Scholar
• Stoffel EC, Ulibarri CM, Folk JE, Rice KC, Craft RM. 2005. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. J Pain 6:261–274.
   PubMed Web of Science ®Google Scholar
• Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O’Brien CP. 1998. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and ß-funaltrexamine on ethanol consumption in the rat. Alcohol 15:281–289.
   PubMed Web of Science ®Google Scholar
• Takemori AE, Larson DL, Portoghese PS. 1981. The irreversible antagonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 70:445–451.
   PubMed Web of Science ®Google Scholar
• Vitale MA, Chen D, Kanarek RB. 2003. Chronic access to a sucrose solution enhances the development of conditioned place preferences for fentanyl and amphetamine in male long-evans rats. Pharmacol Biochem Behav 74:529–539.
   PubMed Web of Science ®Google Scholar
• Walker EA, Tiano MJ, Benyas SI, Dytstra LA, Picker MJ. 1999. Naltrexone and ß-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene. Psychopharmacology 144: 45–53.
   PubMed Web of Science ®Google Scholar
• Ward SJ, Portoghese PS, Takemori AE. 1982a. Pharmacological profiles of ß-funaltrexamine (ß-FNA) and ß-chlomaltrexamine (ß-CAN) on the mouse vas deferens preparation. Eur J Pharmacol 80:377–384.
   PubMed Web of Science ®Google Scholar
• Ward SJ, Portoghese PS, Takemori AE. 1982b. Pharmacological characterization in vivo of novel opioid, ß-funaltrexamine. J Pharmacol Exp Ther 220:494–498.
   PubMed Web of Science ®Google Scholar
• Ward SJ, Fries DS, Larson DL, Portoghese PS, Takemori AE. 1985. Opioid receptor binding characteristics of the non-equilibrium ^.-antagonist, ß-funaltrexamine (ß-FNA). Eur J Pharmacol 107:323–330.
   PubMed Web of Science ®Google Scholar
• Welch CC, Kim EM, Grace MK, Billington CJ, Levine AS. 1996. Palatability-induced hyperphagia increases hypothalamic dynor- phin peptide and mRNA levels. Brain Res 721:126–131.
   PubMed Web of Science ®Google Scholar
• Yeomans MR, Clifton PG. 1997. Exposure to sweetened solutions enhances the anorectic effect of naloxone but not d-fenflur- amine. Physiol Behav 62:255–262.
   PubMed Web of Science ®Google Scholar
• Zimmerman DM, Leander JD, Reel JK, Hynes MD. 1987. Use of ß- funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. J Pharmacol Exp Ther 241:374–378.
   PubMed Web of Science ®Google Scholar